Global Fluorescent In Situ Hybridization (FISH) Probe Market is valued USD 551.02 billion in 2016 is anticipated to grow USD 976.1 billion with the compounded annual growth of 6.56% over the forecast period 2018-2025.
New York 16 Aug 2018, As per the new research study conducted by Bizwit Research & Consulting, Global Fluorescent In Situ Hybridization (FISH) Probe market industry is poised to raise USD 976.1 billion by 2025. The major factors expected to augment the market are rising requirements for In Vitro Diagnostics (IVD) testing in the diagnosis of various chronic diseases and escalating needs for IVD is attributed towards the high levels of reliability, rapidity, and sensitivity. Fluorescent in situ hybridization is a molecular cytogenetic technique that uses fluorescent probes that bind to only those parts of the chromosome with a high degree of sequence complementarity.
To view the summary or to request a sample copy of this report, please click the link mentioned below:
Global Fluorescent In Situ Hybridization (FISH) Probe Market Size Study By Application (Genetic Diseases, and Cancer Research), By RNA Type (miRNA, mRNA, and Others), By End-Use (Clinical, Research, and Companion Diagnostics), and By Regional (North America, Europe, Asia Pacific, Latin America, and Rest of the World) Forecasts, 2018-2025
The industry is seeming to be fairly competitive. Some of the leading market players include NEC Corporation, 3M Cogent, Aware Inc., Animetrics Inc., Precise Biometrics, Aurora Computer Services Ltd., Ayonix Inc., Nuance Communications, FaceFirst, Safran Group, and so on. The fierce competitiveness has made these players spend in product developments to improve the customer’s requirements.
Key findings of the study:
- The North American region accounted for the leading market share, more than XX % of the total market in 2016.
- The Asia Pacific region will be the highest growing segment with respect to geographical segmentation, the region is likely to grow by XX% CAGR over the forecast period 2018-2025
Bizwit Research & Consulting LLP has considered following segments for the study:
- Genetic diseases
- Cancer research
By RNA Type:
- Companion Diagnostics
- North America
- Asia Pacific
- Latin America
- Rest of the World